南京大学医学院附属鼓楼医院Nanjing Drum Tower Hospital

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Nanjing 南京市

   已发表研究

   • Oral GSDMD-N mRNA Nanoparticle-Induced Pyroptosis for the Treatment of Colorectal Cancer. Small (Weinheim an der Bergstrasse, Germany), 2026
   • Targeting LGALS1 via CAF-Derived Extracellular Vesicles Synergizes With αPD-1 to Reverse Immunosuppression and Sensibilize Chemo-Immunotherapy for Colorectal Cancer. Macromolecular bioscience, 2026

   另有 4 项已发表研究

   PubMed 收录了 6 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Gastroenterology 获提名。

2. Breast cancer

   Nanjing 南京市

   已发表研究

   • A Droplet-Microarray Platform for Multiplex Profiling of Breast Cancer Exosome Subtypes in Patients’ Blood Plasma Samples. Small (Weinheim an der Bergstrasse, Germany), 2026
   • Integrative Multi-scale Radiomics and Interpretable AI for Prediction and Burden Stratification of Axillary Lymph Node Metastasis in Breast Cancer. Ultrasound in medicine & biology, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Gastroenterology 获提名。

3. Liver cancer

   Nanjing 南京市

   已发表研究

   • Integrating lipidomics and network pharmacology reveals Valproic acid remodels the lipid metabolic microenvironment in hepatocellular carcinoma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2026
   • IL-11 drives Treg cell differentiation by activating the MBD3/APOH-mediated fatty acid oxidation axis to promote hepatocellular carcinoma. Chinese medical journal, 2026

   另有 4 项已发表研究

   PubMed 收录了 6 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Gastroenterology 获提名。

4. Stomach cancer

   Nanjing 南京市

   已发表研究

   • JAK2 degradation by strebloside dismantles PD-L1-mediated immune evasion in EBV-associated gastric cancer. Translational research : the journal of laboratory and clinical medicine, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Gastroenterology 获提名。

5. Esophageal cancer

   Nanjing 南京市

   已发表研究

   • RHBDD2 Confers Insensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Ferroptosis Through the Wnt3a/β-Catenin/FTH1 Axis. Cell biochemistry and biophysics, 2026
   • Integrated Metabolomics, Network Pharmacology, and Experimental Validation Elucidate the Mechanisms Underlying Dingxiang-Guanshitong Decoction in the Treatment of Esophageal Squamous Cell Carcinoma. Combinatorial chemistry & high throughput screening, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Gastroenterology 获提名。